|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.62 USD | -0.11% |
|
-9.26% | +5.56% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 20.75 | 25.25 | 33.75 |
| Spread/Res. | -10.27% | -26.26% | -44.83% |
| Spread/Supp. | +9.08% | +14.23% | +12.17% |
| Support | 17.07 | 16.3 | 16.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
